Antonio Antela was born in Las Palmas (Canary Islands, Spain) in 1960. He achieved his Medical Doctor degree in 1983 and the Internal Medicine specialty in 1989, both at the University of Santiago de Compostela. Between 1989 and 1991 he made a Fellowship in Infectious Diseases in the Ramón y Cajal Hospital, in Madrid, and from 1991 to 2006 he worked continuously as an Attending Physician in the HIV Unit of the Infectious Disease Department of Ramón y Cajal Hospital, being responsible of the management and follow-up of over 1000 HIV-infected patients. He obtained his Ph. D. degree in 1999. He moved in 2006 to the HIV and Infectious Diseases Department of the University Hospital of Santiago de Compostela, where he continues his clinical and research work in the Infectious Diseases and HIV fields.
He has been author or co-author of 148 articles in peer-reviewed international medical journals and more than 90 book chapters, mainly in the field of HIV infection, and Principal Investigator of more than 70 clinical trials, principally involving antiretroviral drugs. He has also worked in the AIDS Program of the Panamerican Health Organization (PAHO), in Washington, DC, USA, in 2003, and in the NGO Vihda AIDS Clinic in Maragwa (Kenya), in 2004. Currently, he is part of the Directive of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and co-author of the Official Antiretroviral Therapy Guidelines of the Spanish Ministry of Health and the Spanish AIDS Study Group (GESIDA).
His principal field of interest is antiretroviral therapy, mainly in the aspects of efficacy, toxicity, resistance, adherence and simplification. He is also involved in European working groups on the topics of adherence to antiretroviral therapy (European HIV Adherence Network, EHAN), access to HIV diagnosis and care, and initial antiretroviral therapy (Better Equipped for Starting Treatment Programme, BEST).
